Clinical Trial Update: Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating carboplatin/paclitaxel with or without investigational CS-7017 in metastatic non-small cell lung cancer has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non Small Cell Lung Cancer

Drugs mentioned

• CS-7017
• carboplatin/paclitaxel

Snippet

Sponsor: Daiichi Sankyo | Conditions: Metastatic Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-05-13